Aztreonam-avibactam activity against Enterobacterales from Asia Pacific and Latin American medical centres: Summary of 5 years of surveillance prior to clinical use (2020–2024)

International Journal of Antimicrobial Agents · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles